Avior Wealth Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Avior Wealth Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-12	Closed	-$1K	–	1283
2021 Q4	$1K	Hold	12	–	–	﹤0.01%	1076
2021 Q3	$0	Hold	12	–	–	﹤0.01%	1223
2021 Q2	$0	Buy	+12	New	+$782	﹤0.01%	1166

Avior Wealth Management's ARNA Position: Q1 2022 in Review

Avior Wealth Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 12 shares — an estimated $1K sold.

Avior Wealth Management first reported a position in ARNA in Q2 2021 and held it in 3 quarters. The position peaked at $1K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Avior Wealth Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Avior Wealth Management sold 12 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $1K.
Avior Wealth Management first reported a position in Arena Pharmaceuticals Inc in Q2 2021 and held it in 3 quarters.
Avior Wealth Management's Arena Pharmaceuticals Inc position peaked at $1K in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Avior Wealth Management's 13F filing for Q1 2022, filed 13 May 2022.